These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32605679)

  • 1. Registry-based trials: a potential model for cost savings?
    Anderson BR; Gotlieb EG; Hill K; McHugh KE; Scheurer MA; Mery CM; Pelletier GJ; Kaltman JR; White OJ; Trachtenberg FL; Hollenbeck-Pringle D; McCrindle BW; Sylvester DM; Eckhauser AW; Pasquali SK; Anderson JB; Schamberger MS; Shashidharan S; Jacobs JP; Jacobs ML; Boskovski M; Newburger JW; Nathan M;
    Cardiol Young; 2020 Jun; 30(6):807-817. PubMed ID: 32605679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness model comparing dual-mobility to fixed-bearing designs for total hip replacement in France.
    Epinette JA; Lafuma A; Robert J; Doz M
    Orthop Traumatol Surg Res; 2016 Apr; 102(2):143-8. PubMed ID: 26803224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining key design elements of registry-based randomised controlled trials: a scoping review.
    Karanatsios B; Prang KH; Verbunt E; Yeung JM; Kelaher M; Gibbs P
    Trials; 2020 Jun; 21(1):552. PubMed ID: 32571382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Risk.
    Baron SJ; Wang K; House JA; Magnuson EA; Reynolds MR; Makkar R; Herrmann HC; Kodali S; Thourani VH; Kapadia S; Svensson L; Mack MJ; Brown DL; Russo MJ; Smith CR; Webb J; Miller C; Leon MB; Cohen DJ
    Circulation; 2019 Feb; 139(7):877-888. PubMed ID: 30586747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Budgeting of non-commercial clinical trials: development of a budget tool by a public funding agency.
    Nevens H; Harrison J; Vrijens F; Verleye L; Stocquart N; Marynen E; Hulstaert F
    Trials; 2019 Dec; 20(1):714. PubMed ID: 31829233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk.
    Fairbairn TA; Meads DM; Hulme C; Mather AN; Plein S; Blackman DJ; Greenwood JP
    Heart; 2013 Jul; 99(13):914-20. PubMed ID: 23696198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
    Ekpu VU; Brown AK
    Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.
    Saborido CM; Hockenhull J; Bagust A; Boland A; Dickson R; Todd D
    Health Technol Assess; 2010 Jun; 14(31):iii-iv, 1-75. PubMed ID: 20569652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating the Societal Benefits of THA After Accounting for Work Status and Productivity: A Markov Model Approach.
    Koenig L; Zhang Q; Austin MS; Demiralp B; Fehring TK; Feng C; Mather RC; Nguyen JT; Saavoss A; Springer BD; Yates AJ
    Clin Orthop Relat Res; 2016 Dec; 474(12):2645-2654. PubMed ID: 27699631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is this study feasible? Facilitating management of pragmatic trial planning milestones under a phased award funding mechanism.
    Lipman PD; Dluzak L; Stoney CM
    Trials; 2019 May; 20(1):307. PubMed ID: 31146778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost effectiveness of memantine in Alzheimer's disease: an analysis based on a probabilistic Markov model from a UK perspective.
    Jones RW; McCrone P; Guilhaume C
    Drugs Aging; 2004; 21(9):607-20. PubMed ID: 15260515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-saving analysis of screening colonoscopy in Germany.
    Sieg A; Brenner H
    Z Gastroenterol; 2007 Sep; 45(9):945-51. PubMed ID: 17874356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-utility analysis of bariatric surgery.
    Borisenko O; Lukyanov V; Ahmed AR
    Br J Surg; 2018 Sep; 105(10):1328-1337. PubMed ID: 29667178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Budget Impact Model of Hemophilia Bypassing Agent Prophylaxis Relative to Recombinant Factor VIIa On-Demand.
    Mehta DA; Oladapo AO; Epstein JD; Novack AR; Neufeld EJ; Hay JW
    J Manag Care Spec Pharm; 2016 Feb; 22(2):149-57. PubMed ID: 27015254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cost effectiveness of posaconazole versus fluconazole/itraconazole in the prophylactic treatment of invasive fungal infections in Mexico].
    Rely K; Alexandre PK; Escudero GS
    Value Health; 2011; 14(5 Suppl 1):S39-42. PubMed ID: 21839897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Registry-based randomized controlled trials merged the strength of randomized controlled trails and observational studies and give rise to more pragmatic trials.
    Mathes T; Buehn S; Prengel P; Pieper D
    J Clin Epidemiol; 2018 Jan; 93():120-127. PubMed ID: 28951111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Cost-Effectiveness of Dual Mobility Implants for Primary Total Hip Arthroplasty: A Computer-Based Cost-Utility Model.
    Barlow BT; McLawhorn AS; Westrich GH
    J Bone Joint Surg Am; 2017 May; 99(9):768-777. PubMed ID: 28463921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dedicated Perioperative Hip Fracture Comanagement Programs are Cost-effective in High-volume Centers: An Economic Analysis.
    Swart E; Vasudeva E; Makhni EC; Macaulay W; Bozic KJ
    Clin Orthop Relat Res; 2016 Jan; 474(1):222-33. PubMed ID: 26260393
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.